ERBB2 and breast cancer: As breast cancer is a heterogeneous disease which could be grouped into Luminal A, Luminal B, HER2-enriched, and Triple negative subtypes, we further explored the relationship of EZH2 and STAT3 expression with survival of patients in breast cancer subtypes (Figure S1).